Следене
Scott W. Woods
Scott W. Woods
Yale University School of Medicine
Потвърден имейл адрес: yale.edu
Заглавие
Позовавания
Позовавания
Година
Chlorpromazine equivalent doses for the newer atypical antipsychotics
SW Woods
Journal of Clinical Psychiatry 64 (6), 663-667, 2003
24002003
Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to …
TJ Miller, TH McGlashan, JL Rosen, K Cadenhead, J Ventura, ...
Schizophrenia bulletin 29 (4), 703-715, 2003
20232003
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America
TD Cannon, K Cadenhead, B Cornblatt, SW Woods, J Addington, ...
Archives of general psychiatry 65 (1), 28-37, 2008
16792008
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial
DH Barlow, JM Gorman, MK Shear, SW Woods
Jama 283 (19), 2529-2536, 2000
16342000
Multicenter collaborative panic disorder severity scale
MK Shear, TA Brown, DH Barlow, R Money, DE Sholomskas, SW Woods, ...
American journal of psychiatry 154 (11), 1571-1575, 1997
12001997
Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and …
TJ Miller, TH McGlashan, JL Rosen, L Somjee, PJ Markovich, K Stein, ...
American Journal of Psychiatry 159 (5), 863-865, 2002
10622002
Symptom assessment in schizophrenic prodromal states
TJ Miller, TH McGlashan, SW Woods, K Stein, N Driesen, CM Corcoran, ...
Psychiatric quarterly 70, 273-287, 1999
8251999
The psychosis-risk syndrome: handbook for diagnosis and follow-up
T McGlashan, B Walsh, S Woods
Oxford University Press, 2010
8002010
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis
TH McGlashan, RB Zipursky, D Perkins, J Addington, T Miller, SW Woods, ...
American Journal of Psychiatry 163 (5), 790-799, 2006
7452006
Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk
TD Cannon, Y Chung, G He, D Sun, A Jacobson, TGM Van Erp, ...
Biological psychiatry 77 (2), 147-157, 2015
6722015
An individualized risk calculator for research in prodromal psychosis
TD Cannon, C Yu, J Addington, CE Bearden, KS Cadenhead, ...
American Journal of Psychiatry 173 (10), 980-988, 2016
6262016
At clinical high risk for psychosis: outcome for nonconverters
J Addington, BA Cornblatt, KS Cadenhead, TD Cannon, TH McGlashan, ...
American Journal of Psychiatry 168 (8), 800-805, 2011
6032011
Fear‐potentiated startle in humans: Effects of anticipatory anxiety on the acoustic blink reflex
C Grillon, R Ameli, SW Woods, K Merikangas, M Davis
Psychophysiology 28 (5), 588-595, 1991
5911991
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study
SW Woods, J Addington, KS Cadenhead, TD Cannon, BA Cornblatt, ...
Schizophrenia bulletin 35 (5), 894-908, 2009
5712009
Serotonin function in anxiety: II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects
DS Charney, SW Woods, WK Goodman, GR Heninger
Psychopharmacology 92, 14-24, 1987
5631987
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis
LJ Seidman, AJ Giuliano, EC Meyer, J Addington, KS Cadenhead, ...
Archives of general psychiatry 67 (6), 578-588, 2010
5232010
Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification
P Fusar-Poli, M Cappucciati, S Borgwardt, SW Woods, J Addington, ...
JAMA psychiatry 73 (2), 113-120, 2016
5112016
Therapists, therapist variables, and cognitive-behavioral therapy outcome in a multicenter trial for panic disorder.
JD Huppert, LF Bufka, DH Barlow, JM Gorman, MK Shear, SW Woods
Journal of consulting and clinical psychology 69 (5), 747, 2001
4832001
Dose equivalents for second-generation antipsychotics: the minimum effective dose method
S Leucht, M Samara, S Heres, MX Patel, SW Woods, JM Davis
Schizophrenia bulletin 40 (2), 314-326, 2014
3882014
Co-morbidity and familial aggregation of alcoholism and anxiety disorders
KR Merikangas, DE Stevens, B Fenton, M Stolar, S O'malley, SW Woods, ...
Fear and Anxiety, 97-112, 2013
3882013
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20